Latest Fecal bacteriotherapy Stories
Leading advocacy and disease-awareness nonprofits applauds Centers for Disease Control & Prevention's new study that calls attention to nearly 500,000 Americans afflicted with Clostridium
A process involving transplanting poop to stop symptoms of a nasty disease has caused one woman to gain weight excessively.
As Public Health Preoccupies Americans, Foundation that Fights Deadly Infections Honored Leaders for Significant Contributions to Clostridium Difficile Treatment, Research and Patient Advocacy
A preliminary study has shown the potential of treating recurrent Clostridium difficile infection with oral administration of frozen encapsulated fecal material from unrelated donors, which resulted in an overall rate of resolution of diarrhea of 90 percent.
Results for groundbreaking multi-center study of lead drug candidate RBX2660 (microbiota suspension) presented at IDWeek 2014 PHILADELPHIA, Oct.
Rebiotix microbiota-based drug candidate used to assess a non-antibiotic approach to an urgent public health threat ROSEVILLE, Minn., Sept. 17, 2014 /PRNewswire/ -- Rebiotix Inc.
Phase I/II study also demonstrated SER-109 restoration of a diverse, healthy microbiome CAMBRIDGE, Mass., Sept.
Woodrats lost their ability to eat toxic creosote bushes after antibiotics killed their gut microbes. Woodrats that never ate the plants were able to do so after receiving fecal transplants with microbes from creosote-eaters, University of Utah biologists found.
-- Company Expects to Initiate C. difficile Clinical Trials in 2014 -- ROCKVILLE, Md., June 30, 2014 /PRNewswire/ -- Synthetic Biologics, Inc.
Fecal microbiota transplantation --- the process of delivering stool bacteria from a healthy donor to a patient suffering from intestinal infection with the bacterium Clostridium difficile --- works by restoring healthy bacteria and functioning to the recipient's gut.
- Large; stout; burly.